SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics ($MLTX) is trending due to a significant stock drop following analyst downgrades and concerns over clinical trial data for their drug, sonelokimab, with RBC Capital citing uncompetitive effect size. The community is debating whether the sell-off is an overreaction, with some seeing a buying opportunity due to the company's cash reserves and pipeline, while others express concern over biotech volatility and potential risks. Discussions also include speculation about potential buyouts and the impact of institutional ownership on the stock's price movement.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending, with the community actively engaging in the 'What's UpDog?' joke and highlighting its presence on the $SOL.X network. Community members emphasize that it's been active for over a year and is listed on Jupiter Strict List while also congratulating other trending tickers on being UpDog. The coin is also associated with meme culture, with many users sharing related content and humor.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

$WEEDCOIN.X is trending as community members rally around the crypto's connection to cannabis culture and a shared vision of positivity. Advocates emphasize that $WEEDCOIN.X represents more than just a token; it's a movement towards freedom, community, and growth, aiming to bridge the gap between cannabis enthusiasts and the digital economy.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is trending as investors anticipate data from its nomlabofusp clinical development program for Friedreich's Ataxia, expected sometime this month. Community members are weighing the potential for positive results and a subsequent rise in stock price, while also considering the risk of negative outcomes given the high short interest and upcoming conference call to discuss updates. Some traders are noting unusual options activity, suggesting significant potential movement in either direction post-announcement.

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.

Dogwood Therapeutics Inc.

Dogwood Therapeutics is trending as traders discuss its low float and potential for a significant price surge, drawing comparisons to similar past runners. The community is closely watching for news related to upcoming Phase 2 data on Halneuron and potential partnerships for IMC-1, with some speculating on a potential squeeze due to limited shares available for borrowing.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced private placement of approximately $44 million, sparking significant after-hours trading activity. The community is actively discussing the stock's potential for a short squeeze, noting its small float and high short interest. Some traders are also pointing to potential dilution from warrants associated with the private placement.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following a Morgan Stanley downgrade, citing concerns about Alzheimer's trial risks, prescription trends, pricing pressures, and competition; however, the community is actively debating whether this downgrade is a strategic move to accumulate shares cheaply before positive news emerges, with some suggesting analysts are manipulating the stock for their benefit. While some express concern about the increased competition and potential margin squeeze, others emphasize the company's history of innovation and potential for long-term growth, particularly with its upcoming oral Wegovy and expansion into key markets like India.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals ($ENTA) is trending as investors anticipate topline results from its Phase 2b study of Zelicapavir for RSV, expected to be released soon. Bullish sentiment is building, with some traders hoping for a significant price increase if the data proves positive. The community is actively seeking insights and analysis to gauge the potential outcome of the study.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is trending due to news around potential government funding and strategic initiatives in the rare earth sector, including discussions of reallocating funds from the CHIPS Act. The community is actively discussing the implications of these developments, particularly in relation to domestic supply chains and competition with China. Some are also noting insider selling, as well as upcoming milestones for the company's magnet production and mine development.

SuperVerse is a unified Web3 ecosystem connecting gaming, DeFi, and AI under a single interoperable protocol. Its native token, $SUPER, powers transactions, governance, and access to immersive games, AI-powered tools, and liquidity infrastructure such as Blackhole DEX. Designed for real utility across multiple chains, $SUPER enables staking, protocol buybacks, and sustainable yield while supporting a growing suite of decentralized applications.

SuperFarm

SuperFarm is trending amidst community excitement and speculation about potential catalysts, with some pointing to gaming as a narrative. Bullish sentiment is fueled by observations of strong price action and technical analysis suggesting further upside. The community is actively discussing potential price targets and entry points as the coin experiences increased volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lam Research Stock Trades at Low P/E: Should You Buy, Sell or Hold?

Despite robust growth in AI and HPC, LRCX faces near-term risks tied to China sales and chip cycle swings.

Applied Optoelectronics (AAOI) Reports Q2 Loss, Misses Revenue Estimates

Applied Optoelectronics (AAOI) delivered earnings and revenue surprises of -100.00% and -1.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AXT (AXTI) Reports Q2 Loss, Beats Revenue Estimates

AXT (AXTI) delivered earnings and revenue surprises of -15.38% and +0.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Marvell (MRVL): Can Its 7.1% Jump Turn into More Strength?

Marvell (MRVL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Applied Optoelectronics (AAOI) Moves 17.8% Higher: Will This Strength Last?

Optical stocks rise after Nvidia co-packaged optics announcement

Investing.com -- Shares of optical component companies gained in premarket trading after Nvidia (NASDAQ:NVDA) announced plans to implement co-packaged optics (CPO) in its Spectrum X Ethernet and Quantum X Infiniband platforms. 

Shares of Applied Optoelectronics Inc. (AAOI) skyrocketed over 47% during Thursday’s after-hours trade as the company announced the issue of a warrant to Amazon.com Inc. (AMZN) to purchase up to 7.945 million shares.In a filing with the U.S. Securities and Exchange Commission (SEC), Applied Optoelectronics announced that it has entered into a transaction agreement with Amazon.The agreement ties the vesting of shares to a certain value of purchases Amazon should make from the company.In its filing, Applied Optoelectronics revealed that 1.32 million shares have vested on the date of issuance, and the remaining will vest over a period of 10 years, based on discretionary purchases made by Amazon or its affiliates, up to an aggregate of $4 billion.Subject to Amazon’s purchases from the company achieving this milestone, the company has the option to exercise the warrant on or before Mar. 13, 2035, at an exercise price of $23.6954 per share.Applied Optoelectronics’ stock closed Thursday at $15.87.Last week, analysts at B Riley upgraded the company to ‘Neutral’ from ‘Sell’ with a price target of $13.FinChat data shows the average price target for the Applied Optoelectronics stock is $33.50, implying a 111% upside from current levels.Of the five brokerage recommendations, two have ‘Buy’ and ‘Outperform’ ratings, and one recommends investors to ‘Hold’ the stock.Retail sentiment on Stocktwits around the Applied Optoelectronics stock soared, entering the ‘extremely bullish’ (87/100) territory from ‘bearish’ a day ago.<figure class="image"><img style="aspect-ratio:644/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AAOI_retail_sentiment_jpg_91955c84bd.webp" alt="AAOI retail sentiment.jpg" width="644" height="145"><figcaption>AAOI sentiment and message volume March 13, 2025, as of 9 pm ET | Source: Stocktwits</figcaption></figure>Message volumes saw a massive spike, too, hovering at ‘extremely high’ levels at the time of writing.<a href="https://stocktwits.com/symbol/AAOI">Applied Optoelectronics stock</a> has lost nearly 57% of its value year-to-date (YTD), but its one-year performance is relatively better, with&nbsp;a gain of nearly 14%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ondas-stock-tumbles-on-q4-earnings-miss/ch7d4tuRbRn">Ondas Stock Tumbles On Q4 Earnings Miss, Lower-Than-Expected Guidance – But Retail’s Optimistic</a>

Applied Optoelectronics Rips Aftermarket On Issuing Amazon Warrant For Up To 8M Stock Buy — Retail Turns Exuberant

Applied Optoelectronics and Amazon have entered into a transaction agreement that will vest up to 7.945 million shares upon Amazon or its affiliates making discretionary purchases of up to $4 billion from the company.

Equity

Shares of Applied Optoelectronics Inc. (AAOI) rose by over 3% in after-market hours on Tuesday as the company gears up to post fourth-quarter results on Wednesday.According to Stocktwits data, Applied Optoelectronics is expected to report a loss per share of $0.02 in Q4, flipping from earnings per share (EPS) of $0.04 during the same period last year.Applied Optoelectronics is scheduled to post its Q4 results on Wednesday after markets close.However, on a positive note, the fiber optic cable manufacturing company is expected to post revenue of $99.98 million during the quarter, up more than 65% from the same period last year.During the quarter, the Texas-based company also raised $33.7 million in net proceeds via a registered direct offering of equity shares in December. The company said it would use these funds to meet its capital expenditure and other working capital needs.Subsequently, analysts at Raymond James more than doubled their price target for the stock to $39 from $17 – this implies an upside of over 67% from Tuesday’s closing price. The brokerage has an ‘Outperform’ rating on the stock, according to The Fly.FinChat data shows the average price target for the Applied Optoelectronics stock is $34.25, implying a nearly 47% upside from current levels.Of the four brokerage recommendations, two have a ‘Buy’ rating, one has an ‘Outperform’ rating, and one recommends investors to ‘Sell’ the stock.Applied Optoelectronics has missed earnings expectations in two of the last four quarters, but its revenue track record is worse. It missed estimates in three quarters during this period.Retail sentiment on Stocktwits around the Applied Optoelectronics stock gained momentum to hover in the ‘bullish’ (66/100) territory. Message volume was elevated, too, showing increased interest among investors.<figure class="image"><img style="aspect-ratio:647/148;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AAOI_retail_sentiment_f9cf6a02d8.jpg" alt="AAOI retail sentiment.jpg" width="647" height="148"><figcaption>AAOI sentiment and message volume February 26, 2025, as of 2:30 am ET | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/AAOI">Applied Optoelectronics stock</a> has lost nearly 37% of its value year-to-date (YTD), but its one-year performance is far better, with gains of over 58%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nvidia-q4-earnings-expected-to-skyrocket-as-wall-street-expects-ai-boom-to-continue/chdJPy3RUZ">Nvidia Q4 Earnings Expected To Skyrocket As Wall Street Expects AI Boom To Continue: Retail Thinks AI Bellwether Will Save The Market</a>

Fiber optic cable patch panels are located in the data center of a software service provider

Applied Optoelectronics Stock Jumps Ahead Of Q4 Results, Analysts Expect Topline Boost: Retail’s Bullish

In December, the Texas-based company also raised $33.7 million in net proceeds via a registered direct offering of equity shares. The company said it would use these funds to meet its capital expenditure and other working capital needs.

DeepSeek 'likely a head fake', buy the dip says Rosenblatt's Genovese

Investing.com -- Rosenblatt analyst Mike Genovese believes the recent DeepSeek-related sell-off in the optical and Ethernet networking space is “likely a head fake,” urging investors to buy the dip.

Shares of Applied Optoelectronics tumbled over 8% in mid-day trading on Tuesday,&nbsp;to levels last seen on Nov. 20, after B. Riley downgraded the stock.The brokerage revised its rating on the stock to ‘Sell’ from ‘Neutral,’ keeping the price target of $14.&nbsp;B. Riley expressed concerns about a slowdown in demand for 400 Gigabit Ethernet (G) technology, a key revenue driver for AAOI.&nbsp;The brokerage flagged that without qualification of the faster 800G technology by hyperscalers — large-scale cloud service providers — Applied Optoelectronics could struggle to sustain its quarterly revenue of approximately $100 million, most of which currently comes from its cable TV business.The downgrade also highlighted broader market challenges like the shift to 800G requiring significant infrastructure investment, and the IEEE’s ongoing efforts to establish 800G standards suggest it may take time for widespread adoption.&nbsp;Many hyperscale data centers are still transitioning to 400G technology, a mature and proven standard.&nbsp;Meanwhile, competing technologies like 1.6 Terabit Ethernet (1.6T) are already under development, potentially delaying the industry's move to 800G.<figure class="image"><img style="aspect-ratio:641/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_10_142523_f7245fbc7a.png" alt="Screenshot 2024-12-10 142523.png" width="641" height="145"><figcaption>Applied Optoelectronics Sentiment and Message Volume on Dec 10 as of 2:30 p.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock dipped to ‘bearish’ (29/100) from ‘neutral’ a day ago with chatter remaining in the ‘normal’ territory.Some users on Stocktwits anticipated the stock to fall amid increasing volatility and the bearish trend in the broader technology sector due to Nvidia’s regulatory hurdles.<stembedurl>https://stocktwits.com/StockBraker/message/595838149</stembedurl><stembedurl>https://stocktwits.com/jimmywestone317/message/595826162</stembedurl>Despite the day's losses, Applied Optoelectronics remains up nearly 79% year-to-date, reflecting earlier gains from optimism around its technology roadmap.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsmc-stock-dips-on-monthly-revenue-decline-despite-annual-jump/cJa24tIRip">TSMC Stock Slips As Monthly Revenue Declines Despite 34% Annual Jump: Retail Chatter Soars</a>

Workers use microscopes in the production facility at Applied Optoelectronics Tuesday, May 10, 2016, in Houston.  (Photo by Karen Warren/Houston Chronicle via Getty Images)

Applied Optoelectronics Stock Slides To 4-Week Low After Downgrade, Flagging Revenue Risk: Retail Bearish

B. Riley cited concerns over future revenue given falling demand for Applied Optoelectronics’ 400 Gigabit Ethernet and the lack of a green light to proceed with the upgraded 800G technology. 

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$26.40
Prev Close	$26.34
Open	$26.30
Dividend Yield	0.00%
50-Day Moving Average	$24.97
Beta	2.86
Avg. Volume	5.61M
PE Ratio	-7.67

52-Week High	$44.50
52-Week Low	$9.71
Market Capitalization	$1.61B
EPS (Annual)	-$4.50
Price to Book	3.75
Revenue Per Employee	$75,359.63
Enterprise Value/EBITDA	N/A

AAOI
Applied Optoelectronics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AAOI News

AAOI Applied Optoelectronics Inc